Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as an Elite provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Loc Le is a Gastroenterologist in Baltimore, Maryland. Dr. Le is rated as a Distinguished provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS), Barrett Esophagus, Colonoscopy, and Endoscopy.

Ernest Tsao is a Gastroenterologist in Baltimore, Maryland. Dr. Tsao is rated as a Distinguished provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Hepatitis, Gas Bloat Syndrome, Hepatitis C, Endoscopy, and Gastrectomy.

Dr. Gurakar joined Johns Hopkins from the Nazih Zuhdi Transplantation Institute at the Integris Baptist Medical Center in Oklahoma City, where he was the chief of Hepatology Research and the program director of the Liver Transplantation Medicine/ Hepatology Fellowship. He served at various capacities in the Liver Medicine Section, since its first establishment in 1993. Dr. Gurakar's clinical interests include pre and post-transplant, clinical and endoscopic management of liver diseases and viral hepatitis. His research interests include bioartificial liver dialysis systems and application of total plasma exchange in the treatment of liver disorders. Dr. Gurakar is rated as an Elite provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Hepatitis, Liver Failure, Alcoholic Cirrhosis, Liver Transplant, and Kidney Transplant.

Dr. Onwueme graduated with Distinction from Yale University with dual BSc/MSc degrees in chemistry and received MD and PhD degrees from Weill Cornell Medical College. He completed his Internal Medicine residency at Brigham and Women’s Hospital (Clinical Fellow Harvard Medical School) and his Gastroenterology fellowship at Johns Hopkins University School of Medicine. He is currently the Director of clinical trials at Woodholme Gastroenterology and has an ardent interest in the role of microbial metabolites in gut diseases. Dr. Onwueme prizes commitment to quality and compassionate patient care to which he devotes his practice. He has expert knowledge in gut microbiology and a special interest in diarrheal diseases, disordered gut motility, autoimmune and inflammatory bowel disease. Dr. Onwueme is rated as an Advanced provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Gastric Dysmotility, Diverticular Disease, Diarrhea, Endoscopy, and Gastrectomy.

Eric Blum is a Gastroenterologist in Baltimore, Maryland. Dr. Blum is rated as an Advanced provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Diverticular Disease, Familial Adenomatous Polyposis, Viral Gastroenteritis, Colonoscopy, and Endoscopy.

Agazi Gebreselassie is a Gastroenterologist and a Hospital Medicine provider in Baltimore, Maryland. Dr. Gebreselassie is rated as an Advanced provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Jaundice, Macroamylasemia, Portal Hypertension, Endoscopy, and Colonoscopy.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is rated as a Distinguished provider by MediFind in the treatment of Hepatitis. Her top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy.

Natarajan Ravendhran is a hepatologist specializing in the diagnosis, treatment and management of liver diseases. He received his medical degree from Stanley Medical College, University of Madras in India, completed his residency in internal medicine at what is now Ascension Saint Agnes Hospital in Maryland and a residency in surgery at Railway Hospital in Madras, India. Dr. Ravendhran performed fellowship training in hepatology under the mentorship of Eugene and Leon Schiff at the University of Miami. Additionally, he received fellowship training in gastroenterology and liver disease at the University of Missouri. Dr. Ravendhran received a master’s degree in business administration in medical services management from The Johns Hopkins University. He is a fellow of the American Association for the Study of Liver Diseases and the American Gastroenterological Association, and is a member of the European Association for the Study of the Liver. Dr. Ravendhran is interested in exploring cholestatic disorders. He has participated in many clinical trials that focus on hepatitis B and C, in addition to metabolic dysfunction-associated steatotic liver disease trials. He enjoys teaching, rounding with fellows and seeing patients, and his motto is “Patients come first!”. Dr. Ravendhran is rated as a Distinguished provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Hepatitis, Visceromegaly, Enlarged Liver, and Endoscopy.

Dr. Hamilton is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology. He is the Interim Director, Division of Gastroenterology and Hepatology and the Director of Hepatology for Johns Hopkins Medicine. His clinical specialties include Wilson Disease, Cystic Fibrosis related liver disease, liver transplantation, hepatocellular carcinoma, cirrhosis, portal hypertension, acute and chronic viral, non-alcoholic fatty liver disease (NASH), autoimmune, and cholestatic liver disease. His research interests include the copper homeostasis and its regulation of lipid metabolism and liver injury, the fundamental mechanisms regulating liver fibrosis, and the molecular genetics of hepatocellular carcinoma and early detection biomarkers. Dr. Hamilton is a 2005 recipient of the National Institutes of Health/ National Research Scholar Award for gastroenterology and hepatology. Dr. Hamilton is rated as a Distinguished provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Hepatitis, Esophageal Varices, Autoimmune Hepatitis, Endoscopy, and Carotid Artery Surgery.

Arjun Vaid is a Gastroenterologist in Baltimore, Maryland. Dr. Vaid is rated as an Advanced provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Jaundice, Irritable Bowel Syndrome (IBS), Hiccups, Colonoscopy, and Gastrectomy.

Steven Epstein is a Gastroenterologist in Baltimore, Maryland. Dr. Epstein is rated as an Experienced provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Familial Adenomatous Polyposis, Attenuated Familial Adenomatous Polyposis, Cronkhite-Canada Disease, Gastrectomy, and Colonoscopy.

Paul Thuluvath is a Gastroenterologist in Lutherville, Maryland. Dr. Thuluvath is rated as an Elite provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Liver Failure, Hepatitis, Hepatitis C, Liver Transplant, and Endoscopy.

Edward Wolf is a Gastroenterologist in Baltimore, Maryland. Dr. Wolf is rated as an Experienced provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Diverticular Disease, Gastroesophageal Reflux Disease (GERD), Barrett Esophagus, Colonoscopy, and Gastrectomy.

Dr. Andrea L. Cox is a professor of Internal Medicine at the Johns Hopkins University School of Medicine in the Division of Infectious Diseases and is a member of the Johns Hopkins Kimmel Cancer Center. She holds joint appointments in Oncology and at the Johns Hopkins Bloomberg School of Public Health, in Molecular Microbiology and Immunology. She is an internationally recognized leader in studies of immune responses in immunocompetent and immunocompromised patient populations to viral infections and vaccines against them, including SARS-Co-V-2 (the virus that causes COVID-19), HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Dr. Cox earned her Ph.D. in chemistry from the University of Virginia, where she characterized peptides that drive T cell responses. She then earned her M.D. and completed internal medicine residency and infectious disease fellowship training at Johns Hopkins. She leads the largest prospective cohort study of acute HCV infection, designed to enable detailed molecular analysis of HCV transmission, host immune responses, and virus sequence evolution. She co-led the first prophylactic HCV vaccine trial in individuals at risk of HCV infection. She leads a multidisciplinary international team investigating HCV-specific immune responses to improve vaccine development against HCV, is the lead immunologist on a clinical trial of HBV vaccines in people living with HIV, and co-leads a large team investigating immune responses to COVID-19 infection and vaccines. In addition to her research on viral infections and vaccines, Dr. Cox is actively involved in clinical care of patients with HCV, HIV, and HBV infections. Dr. Cox serves as the director of the Medical Scientist Training Program. A teacher, advisor, and mentor of physician-scientists and scientists, Dr. Cox mentors Ph.D. students in the Johns Hopkins Cellular and Molecular Medicine, Molecular Microbiology and Immunology, and the Immunology graduate training programs. Dr. Cox is rated as an Advanced provider by MediFind in the treatment of Hepatitis. Her top areas of expertise are Hepatitis C, Hepatitis, COVID-19, and HIV/AIDS.

Dr. Po-Hung (Victor) Chen is a transplant hepatology and addiction medicine physician. He is jointly appointed by the Division of Gastroenterology and Hepatology and the Division of Addiction Medicine. Dr. Chen's clinical focus is to care for patients with general or transplant-related liver conditions, including alcohol-associated liver disease (ALD), metabolic dysfunction-associated steatotic liver disease (MASLD), viral hepatitis, autoimmune liver diseases, hemochromatosis, and other diagnoses. He directed the creation of a Johns Hopkins Medicine informational webpage on ALD. He is also a frequent consultant for other Johns Hopkins clinicians regarding inquiries about ALD, including biomarker interpretation, acute hepatitis management, and addiction treatment delivery. Dr. Chen is a member of multiple professional medical and public health organizations (see below). He is a Fellow of the American College of Gastroenterology and a Fellow of the American Society of Addiction Medicine. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Hepatitis, Hepatitis C, Alcoholic Cirrhosis, Liver Transplant, and Endoscopy.

Dr. Moon’s area of clinical expertise is infectious diseases. She earned her M.D. at the Ross University School of Medicine. Dr. Moon completed her residency at Allegheny General Hospital and performed a fellowship in infectious diseases at Penn State Milton S. Hershey Medical Center. Dr. Moon is rated as a Distinguished provider by MediFind in the treatment of Hepatitis. Her top areas of expertise are Hepatitis C, Hepatitis, Osteomyelitis, and HIV/AIDS.

Dr. Benjamin Philosophe is the surgical director of the Johns Hopkins Comprehensive Transplant Center. He also serves as the lead transplant surgeon at Sibley Memorial Hospital’s Hepatology Multidisciplinary Center. Dr. Philosophe was the first physician to perform robotic total right and total left hepatic resections in the state of Maryland. He has expanded the application of minimally invasive surgical approaches to other hepatobiliary diseases and has improved outcomes and reduced effects of surgery on these patients. Dr. Philosophe practices out of The Johns Hopkins Hospital in Baltimore, Md., as well as Johns Hopkins Community Physician locations in Bethesda, Md. and Lutherville, Md. He is also affiliated with Suburban Hospital and Johns Hopkins Howard County Medical Center. Dr. Philosophe has a wide range of expertise, including cirrhosis; hepatic surgery, hepatitis, hepatobiliary conditions and surgeries; biliary tract surgery and hepatopancreatobiliary surgery; laparoscopic surgeries; vascular surgery; and robotic surgeries. He also has an expertise in various kinds of transplant surgeries, such as kidney, live donor liver, liver and pancreas, as well as various kinds of cancer, such as bile duct, gallbladder, hepatocellular, liver and pancreatic. Dr. Philosophe earned his medical degree from Boston University School of Medicine. He completed a residency in general surgery at Barnes-Jewish Hospital, followed by a liver transplantation fellowship at the University of Toronto. Dr. Philosophe also completed a transplant surgery fellowship at the University of Maryland, where he went on to work as a professor of surgery and the head of liver transplantation and hepatobiliary surgery. Dr. Philosophe is a member of the American Board of Surgery, the Clinical Robotic Surgery Association, the American Society of Transplant Surgeons, the Transplantation Society and the International Liver Transplantation Society. He has earned a Super Doctors Award in general surgery from the Washington Post Magazine, as well as a Top Doctor Award for hepatobiliary surgery and transplant specialists from Baltimore Magazine. Dr. Philosophe has also been repeatedly named one of America’s Top Doctors and one of America’s Top Doctors for Cancer by Castle Connolly. Dr. Philosophe has contributed to numerous publications and presentations. His research interests include uncovering the mechanisms that contribute to transplant rejection and determining characteristics that can be used to better predict donor organ function. He has completed pioneering work in developing a scoring system called the Maryland Aggregate Pathology Index (MAPI), which is used by transplant surgeons worldwide to assess the likelihood of a deceased donor’s kidney function after transplantation. MAPI has increased the utilization of donor kidneys and saved many lives. Dr. Philosophe is rated as a Distinguished provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Hepatitis, End-Stage Renal Disease (ESRD), Cholestasis, Liver Transplant, and Kidney Transplant.

Dr. Ashwin Balagopal is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is infectious diseases. After receiving his medical degree from Mount Sinai School of Medicine, Dr. Balagopal completed his residency in internal medicine at Yale-New Haven Hospital. He performed his fellowship in infectious diseases at the Johns Hopkins University School of Medicine. Dr. Balagopal's research interests include microbial translocation and Kupffer cells in HIV-HCV coinfection and in situ liver studies of HIV-HCV pathogenesis. Dr. Balagopal is rated as a Distinguished provider by MediFind in the treatment of Hepatitis. His top areas of expertise are Hepatitis, Hepatitis C, HIV/AIDS, and Hepatitis B.

Specializing in hepatology, Dr. Kim sees patients with chronic viral hepatitis, autoimmune liver diseases, fatty liver disease, abnormal liver enzymes, cirrhosis, portal hypertension, hepatocellular carcinoma and liver transplantation. She has research interests in liver lesions and hepatocellular carcinoma. Dr. Kim has been recognized with numerous awards and has authored several peer-reviewed publications in hepatology. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Hepatitis. Her top areas of expertise are Hepatitis, Fibrolamellar Carcinoma, Macroamylasemia, and Visceromegaly.